This study is the first Iranian research that specifically refers to PAC infection in children. The rates of CLABSI and port infection (cellulitis over the catheter’s port) were 22.8% and 12.8%, respectively. According to the IDSA guideline, the definitive diagnosis of CRBSI needs clinical manifestations of infection (e.g., fever, chills, and/or hypotension) and growth of the same organism from both peripheral blood culture and the catheter tip, or two positive blood cultures by the same bacteria (one from the catheter and the other percutaneously) that meet CRBSI criteria for “Differential Time to Positivity” (DTP) (catheter blood culture is detected positive at least 2 h earlier than a simultaneously drawn peripheral blood of equal volume) or quantitative blood cultures (colony count of catheter blood culture is more than three times of simultaneously drawn peripheral blood of equal volume). Alternatively, when peripheral sampling is difficult, two quantitative blood cultures from different catheter lumens in which the colony count is at least three-fold greater in one of them is indicative of possible CRBSI (
4).
Although quantitative blood culture is the most accurate test for diagnosis of CRBSI, it is not practical in most laboratories, even in the USA (
5). The DTP has poor performance for many common enteric Gram-negative bacteria, and it has low sensitivity (42%) for
S. aureus CRBSI despite high specificity (100%) (
6,
7).
Peripheral sampling in infants and young children is more painful and difficult and thus is not routine practice when a CVC is available. Furthermore, peripheral blood culture sampling in infants uses smaller volumes (1 - 3 cc compared to 10 - 20 cc in adults), and the chance of positive culture drops below 70% in comparison with adults (
8). Practically, for circumstances in which peripheral blood cultures are not obtained, positive blood cultures obtained through a catheter may be presumed to reflect true infection, in the absence of other identifiable sources of infection and in the presence of correlating clinical symptoms. Interestingly in almost all of the published research about PAC infections in children, this practical criterion is used for CRBSI, although for such cases, the term CLABSI is more appropriate (
9).
After a PubMed search for English articles with keywords of “infection of port access catheters in children”, we found a few articles related to our research, which are summarized in
Table 4. In Israel, the rate of CRBSI was 29.6% among 246 children with PAC in pediatric hematology-oncology ward. The rate of catheter extraction due to CRBSI was 61% (
10). In Ankara, Turkey, the rate of pocket infection was 41.5% in 109 children with hematological diseases (with mean catheter duration of 379 days), in comparison with 12.8% in our case series. The rate of CRBSI was 98.1% in Ankara, while it was 22.8% in our group (
11).
In Bengaluru, India, the rates of CRBSI and pocket infection among 209 children with cancer and PAC were 7.6% and 4.3%, respectively, and medical treatment without extraction was successful in 62.5% and 77% of them, respectively (
12). In Singapore, pocket infection and CRBSI were reported in 2.9% and 18.9% of 175 children with cancer and port catheters. Coagulase-negative staphylococci (23.1%),
Klebsiella (13.6%),
Staphylococcus aureus (13.5%), and
P. aeruginosa and
Enterococcus faecalis (each 11.5%) were the most frequent causes of BSI. Medical therapy alone was effective in 69.6% of CRBSI (
13).
In Switzerland, the overall catheter-related infection rate was 0.06% in a relatively old study (1987 - 1997) among 91 children with cancer and port catheter (
14). In another study from Switzerland (Zurich), the rate of CRBSI was 16.5% among 155 children with cancer and PAC. Antibiotic alone without catheter removal was successful in 75%. The median time from implantation to catheter removal due to infection was 122 days. Coagulase-negative staphylococci were responsible for 91% of CRBSI, which led to catheter removal (
15). In Bangalore, India, the rates of catheter-related bacteremia and pocket infection were 4.9% and 4.9% among 122 children with cancer and PAC (
16). In Brazil, the rate of CRBSI was 50% among 188 children with cancer and port catheters. Gram-negative bacteria (46.8%) and Candida (12.8%) were the main causes of infection, and medical treatment without catheter extraction was successful in 97.9% (
17).
This study has some limitations. The first one is its retrospective method. Because of the retrospective nature of the study, it was not possible to determine the place of blood sampling for each case; therefore, our definition of PAC infection was based on clinical signs and any positive blood culture. The second limitation is the method of reporting the rate of catheter infections. The best way to calculate the rate of CRBSI is based on the number of infections per 1000 catheter days. In this study, although we have reported the mean time between catheter implementation and diagnosis of infection (which was 5.3 ± 5.5 months), the rate of infections is based on the number of infections per number of catheters.
In summary, the rate of CLABSI at Sheikh hospital (22.8%) is in the middle range of other studies, but the pocket infection rate (12.8%) is higher than the other comparable reports (
Table 4). This shows the importance of stricter infection control measures in operation rooms and during surgery because the port infection is more related to the implementation procedure, and CRBSI is related to the improper use of catheter during infusion and blood sampling.
| Setting of Study | Number of Patients | CLABSI (%) | Pocket Infection (%) | Rate of Catheter Extraction Because of Infection |
|---|
| Israel hematology | 246 | 29.6 | - | 61 |
| Brazil oncology | 188 | 50 | | 2.1 |
| Turkey hematology | 109 | 98.1 | 41.5 | - |
| India Bengaluru | 209 | 70.6 | 4.3 | 62.5 CRBSI; 77 POCKET |
| Singapore oncology | 175 | 18.9 | 2.9 | 30.4 |
| Switzerland oncology | 155 | 16.5 | - | 25 |
| India oncology | 122 | 4.9 | 4.9 | - |
| Iran (current study) mostly hematology- oncology | 70 | 22.8 | 12.8 | 32 |